CBD RAW oil vs decarboxylated: what do they mean and which one to choose

You are browsing a CBD store and see two seemingly identical bottles with similar concentrations — one labeled as 'RAW', the other as 'decarboxylated' or 'full spectrum'. The price difference is minimal. But the composition and effects can be drastically different. RAW and decarboxylated CBD are not two names for the same product — they are two different chemical profiles with different clinical applications. This article explains everything you need to know to make an informed choice.

KEY INFORMATION
• CBD RAW primarily contains CBDA (cannabidiolic acid) — the inactive form of CBD found in the fresh plant. CBDA converts to CBD through decarboxylation (heating at 110–130°C for 30–60 minutes).
• CBDA has its own pharmacological profile: strong COX-2 inhibition (anti-inflammatory) and antiemetic properties stronger than CBD (Rock et al., British Journal of Pharmacology, 2013).
• Decarboxylated CBD has a broader range of effects: anxiolytic (5-HT1A), sedative (adenosine), analgesic (TRPV1, CB2).
• For inflammatory conditions — RAW (CBDA) may be the better choice. For anxiety, sleep, neuropathic pain — decarboxylated CBD.
• Many full spectrum oils contain a mix of CBD + CBDA — combining both profiles in one product.

What is CBDA and how does CBD form?

To understand the difference between RAW and decarboxylated CBD, one must understand the biosynthesis of cannabinoids in the plant. Hemp does not directly produce CBD or THC — it produces their acidic precursors: CBDA (cannabidiolic acid) and THCA (tetrahydrocannabinolic acid). It is CBDA and THCA that are the dominant cannabinoids in the fresh, living plant.

The conversion of CBDA to CBD occurs through decarboxylation — a chemical reaction in which the CBDA molecule loses a carboxyl group (-COOH), transforming into CBD and CO₂. Decarboxylation occurs naturally to a small extent during long storage (oxidation) or rapidly when heated. For CBD, critical temperatures are: 110–130°C for 30–60 minutes — complete decarboxylation of CBDA to CBD. Above 160°C — further transformations, including the oxidation of CBD to CBN.

CBD RAW oil is an extract in which heating has been intentionally avoided — CBDA is preserved. The taste is intense, herbal, slightly bitter, and the color is dark green from chlorophyll. Decarboxylated oil has undergone controlled heating — CBDA has converted to CBD, the color is lighter (golden-amber), and the taste is milder.

How does CBDA work? Is it pharmacologically active?

A common mistake is the belief that CBDA is 'inactive' — that it needs to be decarboxylated to 'activate' its effects. This is an oversimplification that deserves correction. CBDA exhibits its own pharmacological activity, distinct from CBD.

COX-2 Inhibition: CBDA is a strong inhibitor of the enzyme cyclooxygenase-2 (COX-2) — a key enzyme in the pro-inflammatory cascade. COX-2 produces prostaglandins responsible for pain and inflammation. Inhibition of COX-2 is the same mechanism through which NSAIDs (ibuprofen, naproxen) act. Takeda et al. (European Journal of Pharmacology, 2008) demonstrated that CBDA selectively inhibits COX-2 with a clear preference over COX-1, which is a desirable profile (fewer gastrointestinal side effects than with non-selective COX inhibitors).

Antiemetic Properties: Rock et al. (British Journal of Pharmacology, 2013) conducted a comparative study of CBDA and CBD in vomiting models (in ferrets and rats). CBDA showed stronger antiemetic effects than CBD at lower doses — through agonism of 5-HT1A receptors. This finding suggests that CBDA may be biologically active even at doses lower than CBD. This is one of the most frequently cited pieces of evidence for the independent pharmacological activity of CBDA.

5-HT1A Agonism: Like CBD, CBDA shows affinity for 5-HT1A receptors — serotonin receptors involved in regulating anxiety, mood, and vomiting. The anxiolytic mechanism of CBDA is therefore similar to that of CBD, although less clinically studied.

Decarboxylation: how it occurs and what happens to the oil?

Decarboxylation is a simple chemical reaction, but its parameters — temperature and time — are crucial for the quality of the final product. Too low a temperature and too short a time: incomplete decarboxylation, a mixture of CBD and CBDA. Correct temperature (110–130°C for 30–60 min): complete conversion of CBDA to CBD, largely preserving terpenes. Too high a temperature or too long a time: degradation of CBD to CBN (a less desirable cannabinoid), loss of terpenes, deterioration of quality.

A good producer of decarboxylated oil conducts decarboxylation under controlled conditions — usually in an oven or specialized device — and confirms the cannabinoid profile with a COA certificate after the process. The COA of decarboxylated oil should show: CBD as the dominant cannabinoid, CBDA as trace or absent, CBD:CBDA ratio often above 10:1.

An important feature of RAW oil: decarboxylation occurs gradually during long storage at room temperature or when exposed to sunlight. If you have an old CBD RAW oil, it may have partially decarboxylated itself — the COA provided at purchase may not reflect the current composition. This is another argument for verifying the COA and buying products with a current production date.

Who is CBD RAW (with CBDA) for?

CBD RAW oil has specific advantages for particular applications where the CBDA profile is desired. Understanding the indications helps assess whether it is the right choice for your needs.

Inflammatory conditions and inflammatory pain: Inhibition of COX-2 by CBDA makes RAW oil particularly beneficial for inflammatory joint conditions (arthritis, rheumatoid arthritis), inflammatory pain, and autoimmune diseases with an inflammatory component. The profile of CBDA as a "natural ibuprofen" (COX-2 inhibition) without the side effects of NSAIDs on the gastric mucosa is an interesting supplemental option.

Nausea and vomiting: Rock et al. (2013) demonstrated that CBDA has stronger antiemetic properties than CBD. Individuals using CBD for nausea (chemotherapy, pregnancy — after consulting a doctor, motion sickness) may benefit more from RAW than from decarboxylated. For nausea resulting from stress or anxiety — decarboxylated CBD (via 5-HT1A) may be more appropriate.

Users preferring "close to nature": RAW oil is an extract closer to the natural profile of the hemp plant — without thermal intervention. For those who value minimal processing of natural products, RAW is a logical choice, provided there is an understanding of its action profile.

When RAW is NOT optimal: For anxiety, insomnia, and neuropathic pain — decarboxylated CBD is a better-researched choice due to its 5-HT1A, TRPV1, and adenosine profile. When precise dosing is needed — decarboxylated CBD is more predictable (full activation). For taste sensitivity — RAW has a more intense, bitter flavor than decarboxylated.

Who is decarboxylated CBD for?

Decarboxylated CBD is the classic, most commonly used, and best-researched form of CBD oil. The vast majority of clinical studies regarding CBD — anxiety, sleep, pain, epilepsy — have been conducted with decarboxylated CBD, not RAW.

Anxiety and stress: The 5-HT1A mechanism and FAAH inhibition (increasing anandamide levels) are well documented for CBD. Shannon et al. (Permanente Journal, 2019) demonstrated a reduction in anxiety in 79.2% of participants at 25 mg CBD — the study used decarboxylated CBD. For anxiety — decarboxylated CBD.

Sleep disorders: The modulation of adenosine receptors by CBD — a mechanism related to sleep — is well described for decarboxylated CBD. For insomnia, decarboxylated is the choice with better clinical data support.

Neuropathic pain: The antagonism of TRPV1 by CBD (reducing hypersensitivity to neuropathic pain) is a mechanism specific to decarboxylated CBD. For neuropathic pain, sciatica, fibromyalgia pain — decarboxylated CBD.

Our observations: Some users who did not achieve satisfactory results with decarboxylated CBD for joint pain reported a significant improvement after switching to RAW oil or products with a higher CBDA content. This is consistent with the COX-2 mechanism of CBDA — for pain of an inflammatory nature (joint, thyroid, autoimmune), CBDA may be more effective than CBD alone due to its different mechanism of action.

How to read COA regarding CBD vs CBDA?

The COA (Certificate of Analysis) from an independent laboratory is the only reliable method to verify the cannabinoid composition of the oil. When choosing between RAW and decarboxylated — the COA should contain separate entries for CBD and CBDA with specific concentrations in mg/ml or mg/g.

How to interpret values on the COA? RAW oil: CBDA clearly dominates (e.g., CBDA 40 mg/ml, CBD 10 mg/ml) — the CBDA:CBD ratio is above 2:1 or even 5:1. Decarboxylated oil: CBD clearly dominates (e.g., CBD 50 mg/ml, CBDA below 5 mg/ml or "ND"). "Full-spectrum oil without decarboxylation": a mixture of CBD and CBDA in various proportions — usually CBD as the dominant, CBDA as a significant secondary. Also check the dates on the COA — an older certificate (over 12 months from production) may not reflect the current composition for RAW oils, which slowly decarboxylate.

How to store CBD RAW oil to prevent decarboxylation?

RAW CBD oil requires more careful storage than decarboxylated oil — heat, light, and time are factors that activate the natural decarboxylation of CBDA to CBD. If you want to maintain the RAW profile throughout its usage:

Keep the oil in the refrigerator (4–8°C) or in a dark, cool place (below 15°C). Avoid exposure to sunlight — UV catalyzes degradation. Do not leave the oil in the car (high summer temperatures can exceed 60°C — rapid decarboxylation and degradation). Use before the expiration date — RAW oils are generally more sensitive to the passage of time than decarboxylated ones.

How to check if the oil has not decarboxylated? Without re-examining the COA — you cannot assess it "by eye". A change in color to a lighter shade or a change in smell (less "grassy") may suggest partial decarboxylation, but it is not a reliable indicator. If the quality of effects has changed over several months of using RAW oil, it may indeed be decarboxylation.

Full Raw oils and mixed: can you have both profiles in one bottle?

Many manufacturers offer CBD oils that contain both CBD and CBDA in various proportions. This is not a mistake or oversight — it is a deliberate technological choice that provides a product with a broader action profile than pure RAW or pure decarboxylated.

A typical full spectrum CBD oil produced using low-temperature CO₂ extraction, without further decarboxylation, contains: CBD as the dominant cannabinoid (60–75% of total cannabinoid mass), CBDA as the second main cannabinoid (20–35%), trace amounts of CBG, CBN, CBC, terpenes, and flavonoids. Such a profile means that you are simultaneously buying the COX-2-inhibiting properties of CBDA and the full therapeutic profile of CBD — without having to choose.

For users with multiple ailments at once (e.g., inflammatory joint pain + anxiety + sleep disorders) — an oil with a natural mix of CBD:CBDA may be a better option than specialized RAW or pure decarboxylated. The key is to know the proportions from the COA and adjust the dosage to your goals. With such a mixed profile, the dosage can be gradually increased, observing which symptoms respond better.

It is also worth mentioning CBGA (cannabigerolic acid) — a precursor to CBDA and THCA, present in trace amounts in RAW oils. CBGA exhibits its own pharmacological properties (research on its action on the PPARγ receptor and lipid metabolism), although it is less studied than CBDA. RAW oils with a wide profile of acidic cannabinoids may contain CBGA as an additional active ingredient.

Chemical stability of RAW CBD vs decarboxylated: what degrades faster?

CBD oils differ not only in their action profile but also in their chemical stability over time — an important factor when choosing a product that we plan to use for many months.

CBDA in RAW oil is less stable than CBD in decarboxylated oil — it gradually converts to CBD when stored for long periods at room temperature. It is estimated that RAW oil stored in the refrigerator loses about 5–10% of CBDA to CBD over a year of storage. When stored at room temperature with exposure to sunlight — the conversion can be much faster. This means that an old RAW oil purchased a year ago may already have a different cannabinoid profile than on the day of purchase.

CBD in decarboxylated oil is more stable — it undergoes slow degradation to CBN upon contact with air and light, but the rate is much slower than the decarboxylation of CBDA. Well-stored decarboxylated CBD oil retains its profile for 12–24 months. You can find an article on storing CBD oils here: How to store CBD oil.

RAW or decarboxylated: choice for specific applications

Below is a summary of indications and the recommended CBD profile for the most common applications. This is a guideline — it does not replace individual medical consultation.

Joint pain, inflammation, rheumatoid arthritis, inflammatory conditions: RAW CBD (with CBDA) — COX-2 inhibition by CBDA is directly relevant. Alternatively: full spectrum with a mixture of CBD and CBDA.

Anxiety, stress, panic attacks: Decarboxylated CBD — the 5-HT1A mechanism is best studied for CBD, not CBDA. Clinical studies on anxiety disorders have focused on CBD.

Sleep disorders, insomnia: Decarboxylated CBD — modulation of adenosine and sedative profile are best studied for CBD. For insomnia resulting from inflammatory pain — consider RAW or a mix.

Nausea, vomiting (motion sickness, post-chemotherapy state, stress): RAW CBD (CBDA) — Rock et al. 2013 demonstrated stronger antiemetic properties of CBDA. For nausea due to stress — decarboxylated CBD may be equally effective.

Neuropathic pain, sciatica: Decarboxylated CBD — TRPV1 antagonism studied for CBD. For mixed pain (neuropathic-inflammatory) — full spectrum with both. A comparison of CBD oils is available in the article Full spectrum vs broad spectrum CBD.

Frequently Asked Questions

What is RAW CBD oil?

RAW CBD oil is an extract from hemp with a dominant CBDA (cannabidiolic acid) — the inactive form of CBD. Not heating preserves CBDA, chlorophyll, and terpenes. CBDA is pharmacologically active: it strongly inhibits COX-2 (anti-inflammatory) and exhibits antiemetic properties stronger than CBD (Rock et al., Br J Pharmacol, 2013).

What is decarboxylated CBD oil?

Hemp extract heated to 110–130°C for 30–60 minutes — CBDA transforms into CBD. Decarboxylated oil contains CBD as the dominant cannabinoid. Most clinical studies regarding anxiety, sleep, and pain have focused on this form of CBD — it has the best-documented efficacy profile.

Which is better: RAW CBD or decarboxylated?

It depends on the purpose. RAW (CBDA) — inflammatory conditions, joint pain, nausea. Decarboxylated CBD — anxiety, sleep, neuropathic pain. Full spectrum with a blend — a broad profile encompassing both mechanisms. Without a COA, it's hard to assess which oil you have in front of you regardless of the label.

What temperature destroys CBD?

CBDA decarboxylates to CBD at 110–130°C for 30–60 minutes. Above 160°C, CBD degrades to CBN (undesirable). Storing at room temperature or in the fridge does not destroy CBD — active heating or a very long time in heat/light is needed for decarboxylation.

Is CBDA active without decarboxylation?

Yes. CBDA strongly inhibits COX-2, exhibits 5-HT1A agonism, and has antiemetic properties. Rock et al. (Br J Pharmacol, 2013) demonstrated stronger antiemetic effects of CBDA than CBD in some models — CBDA is biologically active without the need for activation by heat.

How to recognize RAW CBD oil by appearance?

RAW — dark green color from chlorophyll, intense herbal-grassy aroma, bitter taste. Decarboxylated — lighter, golden-amber color, milder taste. The only sure method: COA from a laboratory with specific values of CBDA and CBD in mg/ml.

The article is informational and educational in nature. It contains internal links to products available in the u Bucha store. Prices and specifications may change — check the current data on the product page before purchasing.

Author: Michał Waluk · Published: 2026-05-04 · Updated: 2026-05-04